Four children with terminal brain cancer survive years after breakthrough cell therapy trial

Four children with terminal brain cancer, previously facing certain death, have survived years after receiving experimental cell therapy.

In a small but striking clinical trial, four children diagnosed with terminal brain cancers — malignancies that had resisted every conventional treatment — have survived for years after receiving a therapy built from their own immune cells. The approach, known as autologous T cell therapy, represents a quiet revolution in how medicine might confront diseases it has long considered beyond reach. Where surgery, radiation, and chemotherapy had exhausted their possibilities, the body's own defenses were trained to finish what those tools could not. For families who had been asked to prepare for lo

Four children with terminal brain cancer survive years after breakthrough cell therapy trial

Cobertura Relacionada

Recibe The Register en tu bandeja